Physician profile
Joseph Seipel
NPI 1043213408
$3,539.76
in general payments reported to CMS, 2019-2025
22 companies · $557 in 2025
The $557 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $368 · 2020: $157 · 2022: $45.53 · 2023: $429 · 2024: $1,983 · 2025: $557.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,174 · Travel and Lodging: $795.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,174.06 |
| Travel and Lodging | $794.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Livanova USA, INC. | $1,563.43 | 2019-2025 | Vns Therapy, Vns Therapy Sentiva Model 1000 Generator |
| Pfizer INC. | $756.30 | 2023-2025 | |
| Abbvie INC. | $527.55 | 2022-2025 | |
| Boston Scientific Corporation | $164.83 | 2023 | Vercise |
| Biogen, INC. | $115.42 | 2019-2025 | Vumerity, Tysabri |
| Sunovion Pharmaceuticals INC. | $92.84 | 2019-2020 | |
| Jazz Pharmaceuticals INC. | $44.01 | 2019-2025 | |
| Novartis Pharmaceuticals Corporation | $40.32 | 2019-2022 | |
| Alexion Pharmaceuticals, INC. | $32.08 | 2019 | |
| Ucb, INC. | $26.49 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $21.29 | 2025 | Wainua |
| Neurelis, INC. | $19.21 | 2023 | Valtoco |
| Arbor Pharmaceuticals, INC. | $17.97 | 2019 | |
| Avanir Pharmaceuticals, INC. | $16.40 | 2019 | |
| Philips North America LLC | $15.96 | 2020 |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $14.50 | 2020 | |
| Biohaven Pharmaceutical Holding Company LTD. | $14.46 | 2022 | |
| Amneal Pharmaceuticals LLC | $12.38 | 2020 | |
| Acadia Pharmaceuticals INC | $11.22 | 2019 | |
| Emd Serono, INC. | $11.11 | 2019 | |
| Eisai INC. | $11.05 | 2020 | |
| Teva Pharmaceuticals USA, INC. | $10.94 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joseph Seipel listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.